awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36218165-9D6A61FF-F1F8-45E5-9F5D-7E66AFA03C34
Q36218165-9D6A61FF-F1F8-45E5-9F5D-7E66AFA03C34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36218165-9D6A61FF-F1F8-45E5-9F5D-7E66AFA03C34
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.
P2860
Q36218165-9D6A61FF-F1F8-45E5-9F5D-7E66AFA03C34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36218165-9D6A61FF-F1F8-45E5-9F5D-7E66AFA03C34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c127d168e6c5be31ad0368d3c7c7b8596118221c
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.